These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 29188570

  • 1. Synergistic Use of GPCR Modeling and SDM Experiments to Understand Ligand Binding.
    Potterton A, Heifetz A, Townsend-Nicholson A.
    Methods Mol Biol; 2018; 1705():335-343. PubMed ID: 29188570
    [Abstract] [Full Text] [Related]

  • 2. GPCR Homology Model Generation for Lead Optimization.
    Tautermann CS.
    Methods Mol Biol; 2018; 1705():115-131. PubMed ID: 29188560
    [Abstract] [Full Text] [Related]

  • 3. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T, Simms J, Christopoulos A, Wootten D, Sexton PM.
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [Abstract] [Full Text] [Related]

  • 4. Modeling and Deorphanization of Orphan GPCRs.
    Diaz C, Angelloz-Nicoud P, Pihan E.
    Methods Mol Biol; 2018 Nov; 1705():413-429. PubMed ID: 29188576
    [Abstract] [Full Text] [Related]

  • 5. Characterization of Ligand Binding to GPCRs Through Computational Methods.
    Vasile S, Esguerra M, Jespers W, Oliveira A, Sallander J, Åqvist J, Gutiérrez-de-Terán H.
    Methods Mol Biol; 2018 Nov; 1705():23-44. PubMed ID: 29188557
    [Abstract] [Full Text] [Related]

  • 6. Methods for Virtual Screening of GPCR Targets: Approaches and Challenges.
    Cross JB.
    Methods Mol Biol; 2018 Nov; 1705():233-264. PubMed ID: 29188566
    [Abstract] [Full Text] [Related]

  • 7. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
    Bhunia SS, Saxena AK.
    Curr Top Med Chem; 2021 Nov; 21(4):269-294. PubMed ID: 32901584
    [Abstract] [Full Text] [Related]

  • 8. Assessing GPCR homology models constructed from templates of various transmembrane sequence identities: Binding mode prediction and docking enrichment.
    Loo JSE, Emtage AL, Ng KW, Yong ASJ, Doughty SW.
    J Mol Graph Model; 2018 Mar; 80():38-47. PubMed ID: 29306746
    [Abstract] [Full Text] [Related]

  • 9. Free fatty acid receptors: structural models and elucidation of ligand binding interactions.
    Tikhonova IG, Poerio E.
    BMC Struct Biol; 2015 Sep 07; 15():16. PubMed ID: 26346819
    [Abstract] [Full Text] [Related]

  • 10. Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity.
    Jaiteh M, Rodríguez-Espigares I, Selent J, Carlsson J.
    PLoS Comput Biol; 2020 Mar 07; 16(3):e1007680. PubMed ID: 32168319
    [Abstract] [Full Text] [Related]

  • 11. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
    Chen H, Fu W, Wang Z, Wang X, Lei T, Zhu F, Li D, Chang S, Xu L, Hou T.
    ACS Chem Neurosci; 2019 Jan 16; 10(1):677-689. PubMed ID: 30265513
    [Abstract] [Full Text] [Related]

  • 12. Benchmarking GPCR homology model template selection in combination with de novo loop generation.
    Szwabowski GL, Castleman PN, Sears CK, Wink LH, Cole JA, Baker DL, Parrill AL.
    J Comput Aided Mol Des; 2020 Oct 16; 34(10):1027-1044. PubMed ID: 32737667
    [Abstract] [Full Text] [Related]

  • 13. New Trends in Inspecting GPCR-ligand Recognition Process: the Contribution of the Molecular Modeling Section (MMS) at the University of Padova.
    Ciancetta A, Cuzzolin A, Deganutti G, Sturlese M, Salmaso V, Cristiani A, Sabbadin D, Moro S.
    Mol Inform; 2016 Sep 16; 35(8-9):440-8. PubMed ID: 27546048
    [Abstract] [Full Text] [Related]

  • 14. A Structural Framework for GPCR Chemogenomics: What's In a Residue Number?
    Vass M, Kooistra AJ, Verhoeven S, Gloriam D, de Esch IJP, de Graaf C.
    Methods Mol Biol; 2018 Sep 16; 1705():73-113. PubMed ID: 29188559
    [Abstract] [Full Text] [Related]

  • 15. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
    Kooistra AJ, Roumen L, Leurs R, de Esch IJ, de Graaf C.
    Methods Enzymol; 2013 Sep 16; 522():279-336. PubMed ID: 23374191
    [Abstract] [Full Text] [Related]

  • 16. Computational Methods Used in Hit-to-Lead and Lead Optimization Stages of Structure-Based Drug Discovery.
    Heifetz A, Southey M, Morao I, Townsend-Nicholson A, Bodkin MJ.
    Methods Mol Biol; 2018 Sep 16; 1705():375-394. PubMed ID: 29188574
    [Abstract] [Full Text] [Related]

  • 17. A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.
    Kooistra AJ, Kuhne S, de Esch IJ, Leurs R, de Graaf C.
    Br J Pharmacol; 2013 Sep 16; 170(1):101-26. PubMed ID: 23713847
    [Abstract] [Full Text] [Related]

  • 18. 7TM Domain Structure of Adhesion GPCRs.
    de Graaf C, Nijmeijer S, Wolf S, Ernst OP.
    Handb Exp Pharmacol; 2016 Sep 16; 234():43-66. PubMed ID: 27832483
    [Abstract] [Full Text] [Related]

  • 19. Molecular Basis of Ligand Dissociation from G Protein-Coupled Receptors and Predicting Residence Time.
    Guo D, IJzerman AP.
    Methods Mol Biol; 2018 Sep 16; 1705():197-206. PubMed ID: 29188564
    [Abstract] [Full Text] [Related]

  • 20. Molecular interaction fingerprint approaches for GPCR drug discovery.
    Vass M, Kooistra AJ, Ritschel T, Leurs R, de Esch IJ, de Graaf C.
    Curr Opin Pharmacol; 2016 Oct 16; 30():59-68. PubMed ID: 27479316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.